CENTYRIN Trademark

Trademark Overview

On Tuesday, November 6, 2018, a trademark application was filed for CENTYRIN with the United States Patent and Trademark Office. The USPTO has given the CENTYRIN trademark a serial number of 88183377. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Johnson & Johnson. The CENTYRIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medical diagnostic preparations comprised of therapeutic proteins for human use for the treatment, prevention, diagnosis and imaging of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases
centyrin

General Information

Serial Number88183377
Word MarkCENTYRIN
Filing DateTuesday, November 6, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical and medical diagnostic preparations comprised of therapeutic proteins for human use for the treatment, prevention, diagnosis and imaging of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 10, 2021SOU EXTENSION 5 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 5 FILED
Thursday, December 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 1, 2021SOU TEAS EXTENSION RECEIVED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 4 GRANTED
Thursday, June 10, 2021SOU EXTENSION 4 FILED
Thursday, June 10, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 3 GRANTED
Thursday, December 3, 2020SOU EXTENSION 3 FILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 12, 2020SOU EXTENSION 2 GRANTED
Friday, June 12, 2020SOU EXTENSION 2 FILED
Friday, June 12, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, November 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019SOU EXTENSION 1 GRANTED
Monday, November 18, 2019SOU EXTENSION 1 FILED
Monday, November 18, 2019SOU TEAS EXTENSION RECEIVED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 11, 2019ASSIGNED TO LIE
Tuesday, February 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 19, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 19, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 14, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 14, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 14, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 12, 2019ASSIGNED TO EXAMINER
Wednesday, November 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 9, 2018NEW APPLICATION ENTERED

Related Keywords

centyrin diseases pain dermatologic system nervous central gastro cardiovascular intestinal ophthalmic